All trials - page: 228

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT05643313Clinical Investigation on Feasibility and Usability of the ABLE Exoskeleton Device for Individuals With Spinal Cord Injury to Perform Skills for Home and Community EnvironmentsABLE Human Motion S.L.
  • Age 18 - 70 yrs
  • Level C5-L5
  • AIS A, B, C, D
  • ≥ 6 months
Ended10NATechnologyStanding/walking/mobility
  • 10 Meter Walking Test (10 MWT)
  • 6-Minute Walk Test (6MWT)
  • Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)
  • Spinal Cord Independence Measure (SCIM)
  • Timed Up and Go Test (TUG)
  • Walking Index for Spinal Cord Injury (WISCI) and WISCI II
  • World Health Organization Quality of Life- BREF (WHOQOL-BREF)
11 weeks25 November 202208 December 20222
NCT05700942AMPLIFY Study: Transcutaneous Spinal Direct Current Stimulation to Enhance Locomotor Rehabilitation After SCIUniversity of Florida
  • Age 18 - 65 yrs
  • Level C1-T12
  • AIS C, D
  • ≥ 1 years
  • be able to walk 3 meters with or without devices, braces, or assistance of one person
  • NOT have diagnosis of other neurologic condition
Recruiting18NATechnologyStanding/walking/mobility
  • 10 Meter Walking Test (10 MWT)
  • 6-Minute Walk Test (6MWT)
  • H reflex
8 weeks10 March 202326 January 20231
NCT03567213Investigation on the Cortical Communication (CortiCom) SystemJohns Hopkins UniversitySingle Group Assignment
  • Age 22 - 70 yrs
  • Level C1-C8
  • AIS A, B, C, D
  • ≥ 1 years
  • NOT have implanted devices incompatible with MRI
Recruiting3Not ApplicableSurgeryGeneral health26 weeks14 December 202125 June 20181
NCT05622994Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryHospital Nacional de Parapléjicos de Toledo
  • Age 18 - 75 yrs
  • Level C4-L1
  • AIS C, D
  • ≥ 1 years
  • NOT have severe bone, kidney, or liver dysfunction
  • NOT have hypothyroidism
80PHASE2DrugGeneral health
  • 10 Meter Walking Test (10 MWT)
  • 6-Minute Walk Test (6MWT)
  • Ashworth and Modified Ashworth Scale (MAS)
  • European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L)
  • Fatigue Severity Scale (FSS)
  • Hospital Anxiety and Depression Scale (HADS)
  • Numeric Pain Rating Scale
  • Penn Spasm Frequency Scale (PSFS)
  • Spinal Cord Independence Measure (SCIM)
120 days01 November 202221 November 20221
NCT05757830PURO - PUlmonary Rehabilitation With O-RAGT PlatformFondazione Don Carlo Gnocchi Onlus
  • Age 18 - 90 yrs
  • Level T2-S5
  • AIS B, C, D
  • All
  • Able to use a walker.
Ended20NATechnologyStanding/walking/mobility
  • 2 Minute Walk Test
48 hours23 December 202207 March 20234
NCT05646810Impact of Peripheral Afferent Input on Central Neuropathic PainUniversity of Aarhus
  • Age 18 - 80 yrs
  • Level C1-T12
  • AIS A, B, C, D
  • ≥ 1 years
20NADrugPain
  • Numeric Pain Rating Scale
95 minutes01 December 202212 December 20220